Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intensive BP Control Reduced Dementia but Increased Brain Atrophy and Hurt Cognition

Publish date:: December 5, 2019

Key clinical point: Intensive blood pressure control reduced dementia relative to standard care, but the benefit also brought risks.

Major finding: The intensively treated group had significantly more brain atrophy, losing a median of 30.6 cm^3, compared with a loss of 26.9 cm³ in the standard treatment group.

Study details: Three subanalyses of the SPRINT MIND study.

Disclosures: SPRINT was funded by the National Institutes of Health. None of the investigators reported having financial conflicts of interest.

Citation:

Nasrallah I et al. CTAD 2019, Abstract S1.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Alzheimer's & Cognition

Vascular dementia risk particularly high in type 2 diabetes,

Mortality burden of dementia may be greater than estimated,

Cognitive deficits complex in youths with type 2 diabetes,

Population study supports migraine-dementia link,

Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease,